XML 45 R23.htm IDEA: XBRL DOCUMENT
v3.24.2

SUBSEQUENT EVENTS | 6 Months Ended
--- | ---
Jun. 30, 2024
Subsequent Events [Abstract] |
SUBSEQUENT EVENTS | SUBSEQUENT EVENTS In July 2024, the Company entered into agreements and plans of mergers to acquire a) JenaValve Technology, Inc., a developer of a catheter-based system to treat patients suffering from aortic regurgitation, a unique disease that affects the aortic valve, for an aggregate cash purchase price of $500.0 million, subject to certain adjustments, plus up to an additional $445.0 million upon achievement of certain regulatory and sales milestones; b) Endotronix, Inc., a developer of an implantable sensor for management of heart failure patients, for an aggregate cash purchase price of $600.0 million, subject to certain adjustments, plus an additional $75.0 million payable for achievement of certain milestones; c) Innovalve Bio Medical Limited, a developer of a transcatheter mitral valve replacement system, for an aggregate cash purchase price of $300.0 million, subject to certain adjustments, plus an additional $25.0 million upon achievement of a certain regulatory milestone. The Company also paid $115.0 million, of which $5.0 million was paid in May 2024 and $110.0 million was paid in July 2024, and may be required to pay up to an additional $200.0 million upon achievement of certain sales milestones to acquire an early-stage medical device company that is developing a catheter-based system to treat patients suffering from a valvular disease.

X
- References No definition available. + Details
Name: | us-gaap_SubsequentEventsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/855/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2 + Details
Name: | us-gaap_SubsequentEventsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration